GO
| HSI1 | 24,231.30 | -138.41 | 383.17B |
| HSCEI1 | 8,914.03 | -24.06 | 180.15B |
| Back Zoom + Zoom - Block Traded | |
|
Brokers' Ratings, TPs & Views on JD HEALTH After Results Ann
2025-03-07 12:26:49 JD HEALTH (06618.HK) once plummeted by 13.6% in early trading. It settled the midday down 9.6% at $36.9, on a turnover of over $1.9 billion. The company announced its 2024 results after the market closed yesterday (6th), in which it reported a turnover of RMB58.16 billion, up 8.6% YoY. Listed below are the latest investment ratings and target prices from four brokers as summarized by our reporters: Broker│Investment Rating│Target Price CLSA│Outperform│$40->$45 BOCI│Buy│$30->$45 HSBC Global Research│Buy->Hold│$33->$43 Goldman Sachs│Buy│$33.5 Broker│Opinion CLSA│Revenue growth accelerated but 2025 net profit may dip BOCI│2H24 profit beat with proactive investment solidifying industry-leading position HSBC Global Research│Positive outlook already reflected in stock price Goldman Sachs│2H24 sales in line, adjusted operating profit missed, and earnings outlook for 2025 conservative ~ AAStocks Financial News Web Site: www.aastocks.com | |